In summary, gugulipid impaired SR-BI–mediated HDL metabolism, caused endothelial dysfunction and liver damage, increased atherosclerosis, and accelerated cardiovascular death in male mice. This evidence concerns the gene SCARB1 and endothelial dysfunction.